Ultraviolet Blood IV Therapy (UVB)

Ultraviolet Blood IV Therapy (UVB)

 

By exposing small amounts of blood to Ultraviolet light, the immune cells can become enhanced.  Studies have shown that UVB IV Therapy can produce anti-inflammatory effects for auto-immune conditions.  One study was a comparison review of two treatments for Psoriasis, UVB vs. Methotrexate.  UVB IV therapy is non-toxic, not harmful and produced identical effects to Methotrexate without any toxicity.  Methotrexate is a form of chemo therapy that is used in treatment of several auto-immune conditions.

We use this therapy for people with auto-immune diseases as well as cancer and infections.  There is a beneficial increase in blood oxygen levels after the treatments and immune enhancement generally occurs after the 3-4th treatment and continues through the 12th session. We suggest a minimum of 1 treatment a week for 12 weeks. Some patients need an aggressive plan and benefit more from 2 per week for 6 weeks.